These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35069597)

  • 21. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated CD54 Expression Renders CD4+ T Cells Susceptible to Natural Killer Cell-Mediated Killing.
    Chen X; Chen H; Zhang Z; Fu Y; Han X; Zhang Y; Xu J; Ding H; Cui H; Dong T; Shang H; Jiang Y
    J Infect Dis; 2019 Nov; 220(12):1892-1903. PubMed ID: 31433832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short communication: Longitudinal changes in peripheral blood NK cells during the first year of HIV-1 Infection in CD4Low and CD4High patient groups.
    Jiao Y; Song J; Zhang Y; Li W; Zhang T; Qi SM; Wu H
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):229-36. PubMed ID: 25386952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
    Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.
    Lima M; Almeida J; Montero AG; Teixeira Mdos A; Queirós ML; Santos AH; Balanzategui A; Estevinho A; Algueró Mdel C; Barcena P; Fonseca S; Amorim ML; Cabeda JM; Pinho L; Gonzalez M; San Miguel J; Justiça B; Orfão A
    Am J Pathol; 2004 Oct; 165(4):1117-27. PubMed ID: 15466379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption.
    Pace M; Ogbe A; Hurst J; Robinson N; Meyerowitz J; Olejniczak N; Thornhill JP; Jones M; Waters A; Lwanga J; Kuldanek K; Hall R; Zacharopoulou P; Martin GE; Brown H; Nwokolo N; Peppa D; Fox J; Fidler S; Frater J
    Front Immunol; 2022; 13():878743. PubMed ID: 36110857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A New Hope for CD56
    Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
    Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection.
    Peña J; Frías M; Castro-Orgaz L; González R; García F; Gallart T; Gatell JM; Plana M;
    Viral Immunol; 2012 Feb; 25(1):37-44. PubMed ID: 22233253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient IL-2 Produced by Activated CD56
    Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
    Front Immunol; 2019; 10():1647. PubMed ID: 31379845
    [No Abstract]   [Full Text] [Related]  

  • 33. Human peripheral blood DNAM-1
    Stannard KA; Lemoine S; Waterhouse NJ; Vari F; Chatenoud L; Gandhi MK; Martinet L; Smyth MJ; Guillerey C
    Blood Adv; 2019 Jun; 3(11):1681-1694. PubMed ID: 31167820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression.
    Cocker ATH; Liu F; Djaoud Z; Guethlein LA; Parham P
    Front Immunol; 2022; 13():992723. PubMed ID: 36211403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-frequency, exhausted immune status of CD56
    Pan Z; Zhao R; Shen Y; Liu K; Xue W; Liang C; Peng M; Hu P; Chen M; Xu H
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108369. PubMed ID: 34844872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High number of CD56(bright) NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections.
    Fregni G; Maresca AF; Jalbert V; Caignard A; Scott-Algara D; Cramer EB; Rouveix E; Béné MC; Capron C
    Virol J; 2013 Jan; 10():33. PubMed ID: 23351719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.
    Nuvor SV; van der Sande M; Rowland-Jones S; Whittle H; Jaye A
    J Virol; 2006 Mar; 80(5):2529-38. PubMed ID: 16474159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
    Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.